News
By Deena Beasley (Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered ...
Patients with untreated chronic hepatitis B and metabolic comorbidities face a higher risk for advanced liver fibrosis and ...
Not all dystopias look the same. We asked the creatives behind five series in the Emmy race to explain how they bring the ...
Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...
Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative ...
18h
The Daily Monitor on MSNGilead pushes on with HIV drug for poor nations despite funding crisisGilead's twice-yearly HIV injection faces headwinds from US aid pullback. Gilead Sciences says it still plans to supply its ...
17hon MSN
"The Handmaid's Tale" comes to an end after six seasons on Hulu. One of the stars, O-T Fagbenle, talks about his character and the show's cultural impact.
The Handmaid's Tale' season 6 dives into June's rebellion and love triangles and the explosive alliances that led to an epic ...
ASCO heard data suggesting that cell therapy may be a way of treating glioblastoma, which has been long seen as incurable.
Community mourns fallen deputy in Mount Gilead; former sheriff urges current leader John Hinton to grieve too amid tragedy ...
As fans of the dystopian TV epic based on Margaret Atwood's hit novel prepare for last series, the actress reflects on its ...
Vepdegestrant, an investigational estrogen receptor (ER) degrader, known as a proteolysis-targeting chimera (PROTAC ), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results